Corporate News 09-Dec-21
Laurus Labs update on acquisition of 26.62% stake in Immunoadoptive Cell Therapy
Laurus Labs announced that the company has paid subscription amount of Rs 27.60 crore in tranche 1 on 09 December 2021 for acquisition of 26.62% stake in Immunoadoptive Cell Therapy at a cash consideration of Rs 46 crore.
Previous News
Laurus Labs Ltd up for third consecutive session
( Hot Pursuit - 02-Jul-24 13:05 )
Volumes soar at Grindwell Norton Ltd counter
( Hot Pursuit - 25-Jan-24 14:30 )
Laurus Labs Ltd spurts 0.01%, gains for five straight sessions
( Hot Pursuit - 04-Apr-24 13:00 )
Laurus Labs fixes record date for interim dividend
( Market Beat - Reports 20-Oct-23 17:57 )
Laurus Labs
( Results - Analysis 27-Apr-23 22:26 )
Laurus Labs to declare Quarterly Result
( Corporate News - 23-Jan-23 11:48 )
Laurus Lab receives affirmation in ratings for bank facilities
( Corporate News - 18-Jun-24 13:53 )
Laurus Labs consolidated net profit declines 84.13% in the September 2023 quarter
( Results - Announcements 20-Oct-23 17:54 )
Laurus Labs to acquire 26.62% stake in Immunoadoptive Cell Therapy
( Corporate News - 19-Nov-21 15:25 )
Laurus Labs consolidated net profit rises 312.35% in the December 2019 quarter
( Results - Announcements 31-Jan-20 10:44 )
Laurus Labs to acquire minority stake in CAR-T cell therapy company
( Hot Pursuit - 19-Nov-21 15:56 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
